Recent Advances in the Treatment of Stage I-IIIA NSCLC

home / insights / recent-advances-in-the-treatment-of-stage-i-iiia-nsclc

An expert panel discusses recent advances in the treatment of Stage I-III NSCLC and their impact on clinical practice.

EP. 1: Coming Soon: Recent Advances in the Treatment of Stage I-IIIA NSCLC

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

December 22nd 2022

EP. 2: Multidisciplinary Care in Non-Small Cell Lung Cancer

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

January 17th 2023

EP. 3: Patient Profile 1: A 57-Year-Old Woman Diagnosed With NSCLC

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

January 17th 2023

EP. 4: Workup and Molecular Testing for a Patient with NSCLC

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

January 24th 2023

EP. 5: Treatment Approach for Patients With Stage IB Disease

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

January 24th 2023

EP. 6: Adjuvant Therapy in Early Stage NSCLC

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

January 31st 2023

EP. 7: Therapies Targeting Specific Molecular Alterations in NSCLC

David Spigel, MD;Jaspal Singh, MD, MHS;David H. Harpole Jr, MD

January 31st 2023

Editorial Board

CancerNetwork.com

OncNursingNews.com

TargetedOnc.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.